334 filings
Page 9 of 17
8-K
s3hzusqk2qt of3
10 Mar 20
Entry into a Material Definitive Agreement
12:00am
424B5
h7c0iyb
10 Mar 20
Prospectus supplement for primary offering
12:00am
SEC STAFF
leuysnhxgln5i00
28 Feb 20
SEC staff action: Order
12:00am
8-K
yiiv9br tb6c
27 Feb 20
T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results
12:10pm
SEC STAFF
xdw7co
6 Feb 20
SEC staff action: Order
12:00am
8-K
vs8lzd
9 Jan 20
T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results
4:47pm
8-K
sn2pwy
9 Jan 20
T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
4:46pm
8-K
8nz9k8xr x0ga0
20 Nov 19
T2 Biosystems Announces Granting ofCE-Mark for T2Resistanceā¢ Panel
7:45am
NT 10-Q
d1o537s
13 Nov 19
Notice of late quarterly filing
4:12pm
8-K
pzo8as
13 Nov 19
T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update
3:19pm
SEC STAFF
w8s 48u09w
12 Sep 19
SEC staff action: Order
12:00am
8-K
ny57xhh
10 Sep 19
Entry into a Material Definitive Agreement
4:35pm
8-K
gr2kug1 0r46x5
10 Sep 19
Entry into a Material Definitive Agreement
4:00pm
SEC STAFF
nh53 24l3iyyw
6 Sep 19
SEC staff action: Order
12:00am
8-K
w6r9zp3blowvq2nh
1 Aug 19
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:32pm
8-K
zj5fqw3 idc2
30 Jul 19
Entry into a Material Definitive Agreement
4:43pm
424B5
a32 x1p1a8er
30 Jul 19
Prospectus supplement for primary offering
4:05pm